General Information
BounceWatch is an independent company data service, not affiliated with Reven Pharmaceuticals. To contact Reven Pharmaceuticals, visit reven.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Reven Pharmaceuticals
Taxonomy: biopharmaceuticals, clinical-stage, vascular treatments, metabolic treatments, health innovation, therapeutics, scientific research, critical limb ischemia, peripheral arterial disease, coronary artery disease, endothelial dysfunction, drug development, clinical trials, medical advancements
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | Undisclosed | - |
|
01 Jan 2019 |
| Series C | Undisclosed | - |
|
01 Jan 2017 |
| Series B | Undisclosed | - |
|
01 Jan 2016 |
| Venture Series Unknown | Undisclosed | - |
|
19 Feb 2015 |
| Series A | Undisclosed | - |
|
01 Jan 2014 |
Reven Pharmaceuticals Alternatives & Competitors
Pioneering medical advancements to improve renal and vascular health through innovative tissue remod...
Cardiovascular Systems, Inc. (CSI) is committed to providing innovative solutions for the revascular...
Pioneering solutions for autoimmune and gastrointestinal health with a promising treatment for celia...
FAQ About Reven Pharmaceuticals
Source: BounceWatch company record for Reven Pharmaceuticals, https://bouncewatch.com/company/reven-pharmaceuticals, updated 28 October 2024. When citing, please name BounceWatch and link this page.